Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
A clinical trial update focusing on collection of blood and urine samples from patients receiving radiation therapy for glioblastoma multifo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors [Phase 1]
Phase 1 trial updating the investigation of HSV-1 G207 for children with recurrent or refractory cerebellar brain tumors; the study is curre…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme [Phase 1]
A Phase 1 clinical trial evaluating B7-H3 CAR T cells (B7-H3CART) for recurrent glioblastoma multiforme is currently recruiting, sponsored b…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: WBSI Guided Personalized Delivery of TTFields [NA]
This clinical trials entry reports that a Penn Medicine Abramson Cancer Center study evaluating WBSI-guided, personalized delivery of tumor-…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients [Phase 2]
Phase 2 clinical trial comparing chemoradiotherapy versus chemotherapy for elderly and frail patients with glioblastoma multiforme; recruitm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
This entry provides an update on an ongoing clinical trial aimed at improving understanding of glioblastoma by preserving biologically activ…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating high-dose ascorbate (vitamin C) for glioblastoma multiforme is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM [Phase 2]
A Phase 2 study evaluating NanO2 combined with radiation and temozolomide in newly diagnosed glioblastoma multiforme is ongoing. The study s…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab [Phase 1, Phase 2]
Clinical trial update for recurrent high-grade glioma treated with APG-157 in combination with bevacizumab, currently recruiting in Phase 1/…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Deciphering Mechanisms Underlying Cancer Immunogenicity [NA]
A clinical trial exploring mechanisms underlying cancer immunogenicity, sponsored by Institut Claudius Regaud; the study is currently recrui…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating QH104 cell injections for malignant brain gliomas, including glioblastoma multiforme and other high-gr…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial [NA]
Pilot trial assessing low-intensity oscillatory magnetic therapy for newly diagnosed glioblastoma multiforme is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
A clinical trial investigating PSMA expression in glioblastoma after VEGF blockade with bevacizumab is currently NOT_YET_RECRUITING. The stu…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Tamoxifen Versus Etoposide After First Recurrence in GBM Patients [Phase 2]
A Phase 2 clinical trial comparing tamoxifen versus etoposide after first recurrence in glioblastoma multiforme patients is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
A clinical trial from Washington University School of Medicine is exploring resting-state MRI combined with machine learning to guide neuron…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Trial of Ipatasertib in Combination With Atezolizumab [Phase 1, Phase 2]
Update on a Phase 1/2 trial of ipatasertib in combination with atezolizumab for solid tumors, including glioblastoma multiforme and metastat…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma [NA]
The document describes a planned clinical trial evaluating a supportive group intervention for caregivers of patients with glioblastoma mult…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
A clinical trial update for photodynamic therapy targeting glioblastoma multiforme using metaverse-based planning and yellow fluorescence im…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) [Phase 1]
A Phase 1 clinical trial investigating a laparoscopically harvested omental autograft to bypass the blood-brain barrier in recurrent gliobla…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
Clinical trial update on spatiotemporal metabolism in autochthonous tumors of glioblastoma patients; the study is currently active but not r…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial update for ERC1671 in combination with GM-CSF and cyclophosphamide for glioblastoma multiforme and gliosarcoma. The s…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of oral OKN-007 in adults with recurrent high-grade glioma. The trial includes patients …
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide [Phase 1]
Phase 1 trial update evaluating lonafarnib in combination with temozolomide for recurrent glioblastoma multiforme and related gliomas.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 clinical trial evaluating JK-1201I in combination with adjuvant temozolomide for newly diagnosed glioblastoma multiforme; currently …
-
CLINICAL_TRIALS research · 2018-04-10Clinical Trial Update: uPAR-PET/MRI in Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating uPAR-PET/MRI in glioblastoma multiforme; the update lists the study status as UNKNOWN.